WHO ICTRP trial
Evaluation of efficacy and safety of Cerebrolysin as add-on therapy in patients…
ISRCTN15233803 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN15233803 |
|---|---|
| Public title | Evaluation of efficacy and safety of Cerebrolysin as add-on therapy in patients with acute stroke after failed recanalisation therapy |
| Scientific title | Efficacy of Cerebrolysin treatment as an add-on therapy to thrombolysis and thrombectomy in severe stroke patients with unsuccessful reperfusion - a prospective single-center clinical study |
| Primary sponsor | University Hospital Centre Zagreb |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Croatia |
| Conditions | Acute ischemic stroke Circulatory System Stroke, not specified as haemorrhage or infarction |
| Interventions | The study group are 20 patients with acute moderate and severe ischemic stroke, treated in University Hospital Centre Zagreb with either thrombolytic therapy alone, or thrombolysis and thrombectomy, who either proven by neuroimaging methods… |
| Registration date | May 25, 2020 |
| Target size | 20 |
| Secondary IDs | Nil known;Nil known;EP - 43/17 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: